Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: Potential mechanisms

Circulation

Volumn 92, Issue 5, 1995, Pages 1117-1125

  Lima, João A C ^a   Judd, Robert M ^b   Bazille, Ann ^b   Schulman, Steven P ^b   Atalar, Ergin ^b   Zerhouni, Elias A ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

edema; magnetic resonance imaging; myocardial infarction; reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION; SCINTIANGIOGRAPHY;

EID: 0029133467     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.5.1117     Document Type: Article

References (36)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:871-874.
2. ISIS 2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
3. Koren GT, Hasin Y, Appelbaum D, Welber S, Rozenman Y, Lotan C, Mosseri M, Sapoznikov D, Luria MH, Gotsman MS. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985;313: 1384-1389.
4. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,229 cases of suspected acute myocardial infarction. Lancet. 1992;339:753-770.
5. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Wellerson J, Williams DO, Waret BL, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation. 1987;76: 142-154.
6. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilatation and function after acute myocardial infarction. J Am Coll Cardiol. 1992; 20:307-313.
7. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
8. Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol. 1985;5:593-598.
9. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. Circulation. 1992;85:1699-1705.
10. Frahm J, Merboldt KD, Bruhn H, Gyngell ML, Hanicke W, Chien D. A 0.3-second FLASH MRI of the human heart. Magn Reson Med. 1990;13:150-157.
11. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelmann R. First-pass nuclear magnetic resonance imaging studies of patients with coronary artery disease. J Am Coll Cardiol. 1991;18:959-965.
12. Van Rugge FP, van der Wall EE, van Dijkman PRM, Louwerenburg HW, de Roos A, Bruschke AVG. Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol. 1992;70:1233-1237.
13. Tscholakoff D, Higgins CB, Sechtem U, McNamara MT. Occlusive and reperfused myocardial infarcts: effect of GD-DTPA on ECG-gated MR imaging. Radiology. 1986;160:515-519.
14. Wolfe CL, Moseley ME, Wikstrom MG, Sievers RE, Wendland MR, Dupon JW, Finkbeiner WE, Lipton MJ, Parmley WW, Brasch RC. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. Circulation. 1989;80:969-982.
15. Schaffer S, Malloy CR, Katz J, Parkey RW, Buja M, Willerson JT, Peshock RM. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol. 1988;12:1064-1072.
16. Saeed M, Wagner S, Wendland MF, Derugin N, Finkbeiner WE, Higgins CB. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP-enhanced MR imaging. Radiology. 1989; 172:59-64.
17. Judd RM, Atalay MK, Rottman GA, Zerhouni EA. Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. Magn Reson Med. 1995;33: 215-223.
18. Clausen M, Bice AN, Civelek AC, Hutchins GM, Wagner HN Jr. Circumferential wall thickness measurements of the human left ventricle: reference data for thallium-201 single-photon emission computed tomography. Am J Cardiol. 1986;58:827-831.
19. Judd RM, Reeder SB, Atalar E, McVeigh ER, Zerhouni EA. A magnetization-driven gradient echo pulse sequence from the Study of Myocardial Perfusion. Magn Reson Med. In press.
20. Zur Y, Wood ML, Neuringer LJ. Spoiling of transverse magnetization in steady state sequences. Magn Reson Med. 1991;21:251-263.
21. Lima JAC, Becker L, Melin JA, Lima S, Kallman CA, Weisfeldt ML. Weiss JL. Impaired thickening of nonischemic myocardium during acute regional ischemia in the dog. Circulation. 1985;71: 1048-1059.
22. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: McGraw Hill: 1971:351-359.
23. Burstein D, Taratuta E, Manning WJ. Factors in myocardial 'perfusion' imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med. 1991;20:299-305.
24. Tweedle MF, Wedeking P, Telser J, Sotak CH, Chang CA, Kumar K, Wan X, Eaton SM. Dependence of MR signal intensity on Gd tissue concentration over a broad range. Magn Reson Med. 1991;22: 191-194.
25. Buja LM, Parkey RW, Stokely EM, Bonte FJ, Willerson JT. Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs. J Clin Invest. 1976;57:1508-1522.
26. Beller GA, Khaw BA, Haher E, Smith TW. Localization of radio-labeled cardiac myosin-specific antibody in myocardial infarcts: comparison with technetium-99m stannous pyrophosphate. Circulation. 1977;55:74-78.
27. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861.
28. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
29. De Roos A, van Rossum AC, van der Wall EE, Postema S, Coombos J, Mathejssen NAA, van Dijkman PRM, Visser FC, van Voorthuisen AE. Reperfused and nonreperfused myocardial infarction: diagnostic potential of GD-DTPA-enhanced MR imaging. Radiology. 1989;172:717-720.
30. Goldman MR, Brady TJ, Pykett IL, Burt CT, Buonanno FS, Kistler P, Newhouse JH, Hinshaw WS, Pohost GM. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation. 1982;66:1012-1016.
31. Nishimura T, Yamada Y, Hayashi M, Kozuka T, Nakatani T, Noda H, Takano H. Determination of infarct size of acute myocardial infarction in dogs by magnetic resonance imaging and gadolinium-DTPA: comparison with indium-111 antimyosin imaging. Am J Physiol Imaging. 1989;4:82-88.
32. Holman ER, van Jongergen HPW, van Dijkman RM, van der Laarse A, de Roos A, van der Wall E. Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardial. 1993;71:1036-1040.
33. Wilke N, Simm C, Zhang J, Ellermann J, Ya X, Merkle H, Path G, Ludemann H, Bache RJ, Ugurbil K. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hypercmia. Magn Reson Med. 1993;29:485-497.
34. Wedeking P, Sotak CH, Telser J, Kumar K, Chang CA, Tweedle MF. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Med. 1992;10:97-108.
35. Crone C, Levitt DG. Capillary permeability to small solutes. In: Renkin EM, Michel CC, Geiger SR, eds. Handbook of Physiology. Bethesda, Md: American Physiological Society; 1984: section 2, vol IV, part II, 411-439.
36. Wolf G. Contrast agents for cardiac MRI. In: Marcus M, Skorton D, Schelbert H, Wolf G, cds. Cardiac Imaging. Philadelphia, Pa: WB Saunders Co; 1991:794-810.